CUSTOMER SERVICE  |  814.355.1030  |  Toll Free: 800.342.3595  |  M-F: 8am-4pm EST/EDT

N-Acetyl-D-erythro-dihydrosphingosine

CATALOG # 1834

Specifications

  • Catalog #:1834
  • Scientific Name:N-Acetyl-D-erythro-dihydrosphingosine
  • Common Name:N-C2:0-D-erythro-Dihydroceramide; N-Acetyl-D-erythro-sphinganine
  • Empirical Formula:C20H41NO3
  • CAS#:13031-64-6
  • SDS:View Safety Data Sheet
  • Data Sheet:View Data Sheet
  • Formula Weight:344
  • Unit:5 mg
  • Solvent:none
  • Source:synthetic
  • Purity:98+%
  • Analytical Methods:TLC, HPLC, identity confirmed by MS
  • Solubility:chloroform/methanol 5:1, ethanol, methanol
  • Physical Appearance:solid
  • Storage:-20°C
  • Dry Ice:No
  • Hazardous:No

Description

Application Notes:

N-Acetyl-D-erythro-dihydrosphingosine is a non-natural analog of the ceramide precursor dihydroceramide. This acetyl dihydroceramide has properties and functions that are different from natural dihydroceramide and is therefore a useful tool for studying dihydroceramides and ceramides. Whereas short chain ceramides potently induce apoptosis in cells neither short nor long-chain dihydroceramides are able to do so.1 N-Acetyl-dihydroceramide has been shown to be incorporated into mitochondria membranes at the same rate as N-acetyl-ceramide and at a greater rate than N-palmitoyl-ceramide. This demonstrates that both dihydroceramide and ceramide insert into the mitochondrial membrane at the same rate indicating that the inability of dihydroceramide to induce apoptosis is not due to a lack of its insertion into the membrane.2 The presence of the 4–5 trans double bond is essential for ceramide-channel formation. Dihydroceramides are unable to form these ceramidechannels due to their lack of a 4-5 double bond and it is suggested that this is the reason for its lack of apoptotic activity.3 Natural dihydroceramide is a critical intermediate in the synthesis of many complex sphingoid bases. Inhibition of dihydroceramide synthesis by some fungal toxins that have a similar structure causes an increase in dihydrosphingosine and dihydrosphingosine-1-phosphate and a decrease in other sphingolipids leading to a number of diseases including oesophageal cancer. N-(4-Hydroxyphenyl) retinamide (4-HPR) has been tested as an anti-cancer agent. It inhibits the dihydroceramide desaturase enzyme in cells resulting in a high concentration of dihydroceramide and dihydro-sphingolipids and this is thought to be the cause of the anti-cancer effects.4

References:
1. F. Bi et al. “A Conserved Cysteine Motif Is Critical for Rice Ceramide Kinase Activity and Function” PLoS ONE 6(3): e18079. doi:10.1371/journal.pone.0018079, 2011
2. L. Siskind et al. “Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations” Mitochondrion, vol. 6 pp. 118- 125, 2006
3. T. Goldkorn et al. “H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells” Journal of Cell Science, vol. 111 pp. 3209-3220, 1998
4. W. Zheng “Fenretinide increases dihydroceramide and dihydrosphingolipids due to inhibition of dihydroceramide desaturase” Georgia Institute of Technology, 2006
Price $84.00

Others Also Bought

Catalog #:
CAS#:
Unit:
$0.00

Customer Reviews

Average Rating
Sign up for news & updates! Sign up!
Please Wait... processing